Results 81 to 90 of about 994,937 (217)
Spatiotemporal dynamics of pacing in models of anatomical reentry [PDF]
Reentry around non-conducting ventricular scar tissue, which often causes lethal arrhythmias, is typically treated by rapid stimulation from an implantable defibrillator. However, the mechanisms of termination (success and failure) are poorly understood.
arxiv
Optimal allocation of defibrillator drones in mountainous regions [PDF]
Responding to emergencies in Alpine terrain is quite challenging as air ambulances and mountain rescue services are often confronted with logistics challenges and adverse weather conditions that extend the response times required to provide life-saving support.
arxiv +1 more source
BACKGROUND Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients.
B. Maron+14 more
semanticscholar +1 more source
AIMS To describe coping strategies and coping effectiveness in recipients with an implantable cardioverter defibrillator and to explore factors influencing coping.
I. Flemme, I. Johansson, A. Strömberg
semanticscholar +1 more source
The widespread use of cardiovascular implantable electronic devices has increased concerns regarding using electronic apex locators in patients with these devices.
Mothanna K. AlRahabi, Hani M. Ghabbani
doaj +1 more source
Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing
Defibrillation testing (DT) does not improve shock efficacy or reduce the risk for arrhythmic death in patients undergoing routine transvenous implantable cardioverter-defibrillator (ICD) placement and is no longer compulsory for left pectoral transvenous ICDs [(1)][1]. The subcutaneous ICD (S-ICD)
William Whang+9 more
openaire +3 more sources
Background: Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Ahmed AlTurki+4 more
doaj
Erosion of an Implantable Cardioverter-Defibrillator
![Figure][1] A 51-year-old man with previous myocardial infarction received a single-chamber implantable cardioverter-defibrillator (ICD) in 2002 for syncope and inducible ventricular tachycardia at electrophysiologic testing.
Darryl Elmouchi, Alan Woelfel
openaire +3 more sources
Patient Alerting Features in Implantable Defibrillators
Implantable cardioverter defibrillators (ICD) are state of the art devices for the primary and secondary prevention of sudden cardiac death.1 As a result, the use of ICDs has increased remarkably over the past years.
Dirk Vollmann+2 more
doaj
Synthesizing Stealthy Reprogramming Attacks on Cardiac Devices [PDF]
An Implantable Cardioverter Defibrillator (ICD) is a medical device used for the detection of potentially fatal cardiac arrhythmia and their treatment through the delivery of electrical shocks intended to restore normal heart rhythm. An ICD reprogramming attack seeks to alter the device's parameters to induce unnecessary shocks and, even more egregious,
arxiv